abstract |
The present invention provides N-isoxazolyl biphenyl sulfonamide compounds of Formula (I), wherein R1, R2, R3, R4, and R5 are as defined herein. These compounds are dual angiotensin and endothelin receptor antagonists, and as such are useful in the treatment of conditions such as hypertension and other diseases. |